Used in pharmaceutical synthesis as a key intermediate for producing tropane alkaloid-based drugs, particularly in the development of anticholinergic agents. Commonly employed in the preparation of medications affecting the central nervous system, including treatments for motion sickness, Parkinson’s symptoms, and certain psychiatric disorders. Its structure supports binding to muscarinic receptors, making it valuable in designing bioactive molecules with central and peripheral nervous system activity. Also utilized in research settings for structure-activity relationship studies of neuroactive compounds.